Skip to main content
Top
Published in: Indian Journal of Surgical Oncology 2/2018

01-06-2018 | Original Article

The Futility of Systematic Lymphadenectomy in Early-Stage Low-grade Endometrial Cancer

Authors: Nidhi Nayyar, Prerna Lakhwani, Ashish Goel, Pankaj Kr. Pande, Kapil Kumar

Published in: Indian Journal of Surgical Oncology | Issue 2/2018

Login to get access

Abstract

Lymphadenectomy is considered an integral part of comprehensive surgical staging of endometrial cancer but debate on the value of lymphadenectomy continues in early-stage endometrial cancer. The aim of our study was to determine the number of node positive patients in clinically early-stage low-grade (G1–G2) endometrioid endometrial cancer. We retro-prospectively analyzed the medical records of 155 women with endometrial pathology coming to the BLK cancer center between January 2015 and December 2017 and studied 60 patients of FIGO grade 1–2 endometrioid endometrial cancer confined to the uterus to determine the nodal positivity. Out of total 60 cases, 2 (3.3%) patients had positive nodes indicating the very low incidence of nodal positivity in clinically uterus confined low-grade endometrioid tumors. Both pelvic and para-aortic lymph nodes were positive in 1 patient. Skip metastases with para-aortic nodal positivity only while pelvic lymph nodes being negative were found in 1 (1.6%) patient. The necessity of comprehensive lymphadenectomy in endometrial cancer remains controversial. Sentinel node mapping can be a reasonably good alternative to strike a balance between systematic lymphadenectomy and no dissection at all in low and intermediate risk endometrial cancer.
Literature
1.
go back to reference Creasman WT (1990) New gynecologic cancer staging. Obstet Gynecol 75:287–288PubMed Creasman WT (1990) New gynecologic cancer staging. Obstet Gynecol 75:287–288PubMed
2.
go back to reference Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Haas LR, Keeney GL, Mariani A, Podratz KC (2012) Prospective assessment of survival, morbidity and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol 127(1):5–10CrossRefPubMed Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Haas LR, Keeney GL, Mariani A, Podratz KC (2012) Prospective assessment of survival, morbidity and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol 127(1):5–10CrossRefPubMed
3.
go back to reference Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study. Lancet 373(9658):125–136CrossRefPubMed Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study. Lancet 373(9658):125–136CrossRefPubMed
4.
go back to reference Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament: atlas of tumor pathology. Bethesda: Armed Forces Institute of Pathology; 1998. 3rd series, Fascicle 23 Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament: atlas of tumor pathology. Bethesda: Armed Forces Institute of Pathology; 1998. 3rd series, Fascicle 23
5.
go back to reference Gallup DG, Stock RJ (1984) Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 64:417–420PubMed Gallup DG, Stock RJ (1984) Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 64:417–420PubMed
6.
go back to reference Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC (2000) Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary ? Am J Obstet Gynecol 182:1506–1519CrossRefPubMed Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC (2000) Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary ? Am J Obstet Gynecol 182:1506–1519CrossRefPubMed
7.
go back to reference Abu-Rustum NR, Chi D, Coleman RL, del Campo JM, Fotopoulou C, Frumovitz M, Gershenson DM, Gonzalez A, Jhingran A, Ledermann J, Mariani A, Mirza M, Oaknin A, Ramirez PT, Schmeler KM, Sood AK (2014) Summary of the 2014 MD Anderson International Meeting in Gynecologic Oncology: emerging therapies in gynecologic cancer. Gynecol Oncol 134:6–9CrossRefPubMed Abu-Rustum NR, Chi D, Coleman RL, del Campo JM, Fotopoulou C, Frumovitz M, Gershenson DM, Gonzalez A, Jhingran A, Ledermann J, Mariani A, Mirza M, Oaknin A, Ramirez PT, Schmeler KM, Sood AK (2014) Summary of the 2014 MD Anderson International Meeting in Gynecologic Oncology: emerging therapies in gynecologic cancer. Gynecol Oncol 134:6–9CrossRefPubMed
8.
go back to reference Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer 60(suppl 8):2035–2041CrossRefPubMed Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer 60(suppl 8):2035–2041CrossRefPubMed
9.
go back to reference Benedetti-Panici P, Maneschi-F CG et al (1998) Anatomical and pathological study of retroperitoneal nodes in endometrial cancer. Int J Gynecol Cancer 8:322–327CrossRef Benedetti-Panici P, Maneschi-F CG et al (1998) Anatomical and pathological study of retroperitoneal nodes in endometrial cancer. Int J Gynecol Cancer 8:322–327CrossRef
10.
go back to reference Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Cliby WA, Gostout BS, Stanhope CR, Wilson TO, Podratz KC (2011) The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer. Gynecol Oncol 123(1):58–64CrossRefPubMed Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Cliby WA, Gostout BS, Stanhope CR, Wilson TO, Podratz KC (2011) The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer. Gynecol Oncol 123(1):58–64CrossRefPubMed
11.
go back to reference Chan JK, Urban R, Cheung MK, Shin JY, Husain A, Teng NN, Berek JS, Walker JL, Kapp DS, Osann K (2007) Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough ? A study of 11,443 patients. Cancer 109(12):2454–2460CrossRefPubMed Chan JK, Urban R, Cheung MK, Shin JY, Husain A, Teng NN, Berek JS, Walker JL, Kapp DS, Osann K (2007) Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough ? A study of 11,443 patients. Cancer 109(12):2454–2460CrossRefPubMed
12.
go back to reference Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, Clarke-Pearson DL, Soper JT (2006) Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high risk histology. Gynecol Oncol 102:92–97CrossRefPubMed Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, Clarke-Pearson DL, Soper JT (2006) Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high risk histology. Gynecol Oncol 102:92–97CrossRefPubMed
13.
go back to reference Abu-Rustum NR, Iasonos A, Zhou Q, Oke E, Soslow RA, Alektiar KM, Chi DS, Barakat RR (2008) Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? Am J Obstet Gynecol 198:457.e1–457.e5 discussion 457.e5-e6CrossRef Abu-Rustum NR, Iasonos A, Zhou Q, Oke E, Soslow RA, Alektiar KM, Chi DS, Barakat RR (2008) Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? Am J Obstet Gynecol 198:457.e1–457.e5 discussion 457.e5-e6CrossRef
14.
go back to reference Chan JK, Wu H, Cheung MK, Shin JY, Osann K, Kapp DS (2007) The outcomes of 27,063 women with unstaged endometrioid cancer. Gynecol Oncol 106:282–288CrossRefPubMed Chan JK, Wu H, Cheung MK, Shin JY, Osann K, Kapp DS (2007) The outcomes of 27,063 women with unstaged endometrioid cancer. Gynecol Oncol 106:282–288CrossRefPubMed
15.
go back to reference Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, Clarke-Pearson DL, Berchuck A (2005) Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23:3668–3675CrossRefPubMed Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, Clarke-Pearson DL, Berchuck A (2005) Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23:3668–3675CrossRefPubMed
16.
go back to reference Kilgore LC, Patridge EE, Alvarez RD et al (1995) Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56:29–33CrossRefPubMed Kilgore LC, Patridge EE, Alvarez RD et al (1995) Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56:29–33CrossRefPubMed
17.
go back to reference Trimble EL, Kosary C, Park RC (1998) Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 71:340–343CrossRefPubMed Trimble EL, Kosary C, Park RC (1998) Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 71:340–343CrossRefPubMed
18.
go back to reference Abu-Rustum NR, Gomez JD, Alektiar KM, Soslow RA, Hensley ML, Leitao MM Jr, Gardner GJ, Sonoda Y, Chi DS, Barakat RR (2009) The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecol Oncol 115:236–238CrossRefPubMed Abu-Rustum NR, Gomez JD, Alektiar KM, Soslow RA, Hensley ML, Leitao MM Jr, Gardner GJ, Sonoda Y, Chi DS, Barakat RR (2009) The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecol Oncol 115:236–238CrossRefPubMed
19.
go back to reference Ballester M, Dubernard G, Rouzier R, Barranger E, Darai E (2008) Use of the sentinel node procedure to stage endometrial cancer. Ann Surg Oncol 15:1523–1529CrossRefPubMed Ballester M, Dubernard G, Rouzier R, Barranger E, Darai E (2008) Use of the sentinel node procedure to stage endometrial cancer. Ann Surg Oncol 15:1523–1529CrossRefPubMed
20.
go back to reference Ballester M, Dubernard G, Lecuru F et al (2011) Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol 12:469–476CrossRefPubMed Ballester M, Dubernard G, Lecuru F et al (2011) Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol 12:469–476CrossRefPubMed
Metadata
Title
The Futility of Systematic Lymphadenectomy in Early-Stage Low-grade Endometrial Cancer
Authors
Nidhi Nayyar
Prerna Lakhwani
Ashish Goel
Pankaj Kr. Pande
Kapil Kumar
Publication date
01-06-2018
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology / Issue 2/2018
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-018-0753-7

Other articles of this Issue 2/2018

Indian Journal of Surgical Oncology 2/2018 Go to the issue